|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/26 | |||
| A61K 9/22 | |||
| A61K 9/36 | |||
| A61K 31/519 |
| (11) | Patento numeris | 2663310 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12703240.7 |
| Europos patento paraiškos padavimo data | 2012-01-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-11-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-05-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/000353 |
| Data | 2012-01-26 |
| (87) | Numeris | WO 2012/100949 |
| Data | 2012-08-02 |
| (30) | Numeris | Data | Šalis |
| 11000677 | 2011-01-27 | EP |
| (72) |
STEFAN, Ralph, DE
SIEVERT, Frank, DE
|
| (73) |
ratiopharm GmbH,
Graf-Arco-Strasse 3, 89079 Ulm,
DE
|
| (54) | ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING TASOCITINIB |
| ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING TASOCITINIB |